General Information: (434) 654-7000 OR 1-800-633-6353
Clinical Trials Offered at Martha Jefferson Hospital
CALGB 70806
Vitamin D and Breast Biomarkers
ECOG 3108
A Phase II Prospective Trial Correlating Progression Free Survival With CYP2D6 Activity in Patients with Metastatic Breast Cancer Treated with Single Agent Tamoxifen (Stage III-IV)
NCIC CTG MA.32
A Phase III Randomized Trial of METFORMIN vs. PLACEBO on Recurrence and Survival in Early Stage Breast Cancer
CALGB 70604
A randomized , Phase III study of standard dosing vs. longer dosing interval of Zoledronic Acid in metastatic bone cancer. (Treatment is every 4 weeks vs. every 12 weeks.)
NCCTGG: N08CB
A Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium/Magnesium in Two Different Versions to Prevent Oxaliplatin-Induced Sensory Neurotoxicity.
ECOG 1505
A Phase III randomized trial of adjuvant chemotherapy with or without Bevacizumab for patients with completely resected Stage IB — IIIA non-small cell lung cancer (NSCLC)
RTOG 0534
A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients with a Rising PSA After Radical Prostatectomy
RTOG 0433/ NCIC CTG SC.20
A Phase III International Randomized Trial of Single VS Multiple Fractions For Re-Irradiation of Painful Bone Metastases
The Impact of Social Work’s Initial Intervention (within 3 days after the start of radiation therapy) in Patients Receiving Palliative Radiation Therapy — Pilot Study (All disease sites)
The Impact of Exercise on Fatigue in Newly Diagnosed Breast Cancer Patients While Receiving Radiation Therapy — Pilot Study (Newly diagnosed breast cancer patients)SWOG = Southwest Oncology Group
ECOG = Eastern Cooperative Oncology Group
RTOG = Radiation Therapy Oncology Group
CALGB = The Cancer and Leukemia Group B